RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Target & Classification

Virus:

EBOVEbola virus

Type:

Viral vector (Non-replicating) vaccine

Diseases:

Ebola Virus Disease

Max Phase:

Phase 2

Clinical Development

Phase 1

Phase 2

Phase 3

Approved

Clinical Trials5

NCT ID	Phase	Disease / Condition
NCT02485912	Phase 1	Ebola Virus Disease
NCT02548078	Phase 2	Ebola Virus Disease
NCT02485301	Phase 2	Ebola Virus Disease
NCT02495246	Phase 1	Ebola Virus Disease
NCT03583606	Phase 1	Ebola Virus Disease